reports
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
- ABGSC Services Research
- Julia Sundvall
- Simon Jönsson
Millicom (Tigo) notice of third quarter 2025 results and video confere...
Millicom (Tigo) notice of third quarter 2025 results and video conference Millicom (Tigo) notice of third quarter 2025 results and video conference Luxembourg, October 16, 2025 – Millicom (NASDAQ: TIGO) expects to announce its third quarter 2025 results on November 6, 2025, via a press release. Millicom is planning to host a video conference for the global financial community on November 6, 2025, at 08:00 (New York) / 13:00 (London). Registration for the interactive event is required at the following . After registering, you will receive a confirmation email containing details about j...
Millicom (Tigo) completes acquisition of Telefónica in Uruguay, streng...
Millicom (Tigo) completes acquisition of Telefónica in Uruguay, strengthening its regional footprint in South America Millicom (Tigo) completes acquisition of Telefónica in Uruguay, strengthening its regional footprint in South America Luxembourg, October 7, 2025 – Millicom International Cellular S.A. (“Millicom”) today announced that, following final approval from the Government of Uruguay, it has completed the acquisition of 100% of Telefónica Móviles del Uruguay S.A. (Movistar) for an enterprise value of USD 440 million. With this milestone transaction, Millicom officially enters the Ur...
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
Millicom (Tigo) subsidiary Telefónica Celular del Paraguay S.A.E. anno...
Millicom (Tigo) subsidiary Telefónica Celular del Paraguay S.A.E. announces its intent to partially redeem Senior Notes due 2027 Luxembourg, September 5, 2025 – Millicom’s subsidiary Telefónica Celular del Paraguay S.A.E (“Telecel Paraguay”) today announced its intent to redeem $150,000,000 aggregate principal amount of its 5.875% Senior Unsecured Notes due 2027 (the “Notes”) on September 15, 2024 (the “Redemption Date”). A notice of redemption will be sent to the holders of the Notes in accordance with the requirements of the indenture governing the Notes (the “Indenture”). Pursuant to the...
- ABGSC Small Cap Research
- Karl Bokvist
- Nikola Kalanoski
- Simon Jönsson
CTT CTT SYSTEMS AB
PREV B PREVAS B
CATE CATENA AB
GENI GENERIC SWEDEN AB PUBL
DUST DUSTIN GROUP AB
EKTA B ELEKTA AB CLASS B
STEF B STENDOERREN FASTIGHETER AB CLASS B
BONEX BONESUPPORT HOLDING AB
HMS HMS NETWORKS AB
MIPS MIPS AB
BOOZT BOOZT AB
A2DRL9 SDIPTECH AB B
FRACTL FRACTAL GAMING GROUP AB
RUG RUGVISTA GROUP AB
PACT PROACT IT GROUP
SFAB SOLID FORSAKRINGSAKTIEBOLAG
NOLA B NOLATO AB
HEM HEMNET GROUP AB (PUBL)
SLP B SWEDISH LOGISTIC PROPERTY AB
ITECH I-TECH AB
VESTUM VESTUM AB
ACAST-SE ACAST
SECT.B-SE SECTRA
GREEN GREEN LANDSCAPING GROUP AB (PUBL)
- ABGSC Financials Research
- Fredrik Flørnes Støle
- Jan Erik Gjerland
- Simon Brun
- ABGSC Financials Research
- Fredrik Flørnes Støle
- Jan Erik Gjerland
- Simon Brun
Millicom (Tigo) Reaches Strategic Agreement with EPM to facilitate Mer...
Millicom (Tigo) Reaches Strategic Agreement with EPM to facilitate Merger Process with ColTel Millicom (Tigo) Reaches Strategic Agreement with EPM to facilitate Merger Process with ColTel Luxembourg, August 14, 2025 – Millicom (Tigo) today announced a key agreement with Empresas Públicas de Medellín (EPM) that advances its acquisition strategy in Colombia and unlocks a path toward the integration of Tigo-UNE and Colombia Telecomunicaciones (ColTel). Under the terms of the agreement: Millicom has committed to present an offer in EPM’s Law 226 sale process, subject to the terms published b...
Millicom (Tigo) Q2 2025 Earnings Release
Millicom (Tigo) Q2 2025 Earnings Release Millicom (Tigo) Q2 2025 Earnings Release Luxembourg, August 7, 2025 – is pleased to announce its second quarter 2025 results. Please find below links to the Q2 2025 Earnings Release and IAS 34 Interim Condensed Consolidated Financial Statements. Q2 2025 Highlights* Revenue $1.37 billion Operating profit $357 million, and record Adjusted EBITDA $641 million Net profit $676 million, including approximately $590 million net profit from infrastructure transactions Equity free cash flow $218 million Leverage of 2.18x, benefiting from one-time c...
Millicom (Tigo) declares $2.50 per share interim dividend to be paid i...
Millicom (Tigo) declares $2.50 per share interim dividend to be paid in two equal installments on October 15, 2025 and April 15, 2026 Luxembourg, August 6, 2025 – In line with the press release published on June 13, 2025, the Board of Directors of Millicom International Cellular S.A. (“Millicom”) approved the interim dividend of $2.50 per share, to be paid in two equal installments of $1.25 per share on October 15, 2025 and April 15, 2026. Other important dates and information relating to the Interim Dividend are as follows: First Installment Interim Dividend Payment First Installment Int...
Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (a...
Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP) Doptelet Sprinkle (avatrombopag) was approved as an effective formulation for children one year to less than six years. The primary endpoint was met in 27.8% of patients, confirming the efficacy in children and adolescents with persistent or chronic ITP WALTHAM, Mass., July 25, 2025 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of (Sobi®), today an...
Millicom (Tigo) notice of second quarter 2025 results and video confer...
Millicom (Tigo) notice of second quarter 2025 results and video conference Millicom (Tigo) notice of second quarter 2025 results and video conference Luxembourg, July 17, 2025 – Millicom expects to announce its second quarter 2025 results on August 7, 2025, via a press release. Millicom is planning to host a video conference for the global financial community on August 7, 2025, at 14:00 pm (Stockholm) / 13:00 (London) / 08:00 (Miami). Registration for the interactive event is required at the following . After registering, you will receive a confirmation email containin...
Swedish Orphan Biovitrum AB: 1 director
A director at Swedish Orphan Biovitrum AB sold 7,723 shares at 288.474SEK and the significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
- ABGSC Services Research
- Julia Sundvall
- Simon Jönsson
- ABGSC Services Research
- Julia Sundvall
- Simon Jönsson
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.